Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients

British Journal of Cancer

Volumn 104, Issue 1, 2011, Pages 37-42

  Nieuwenhuis, M H ^a   Mathus Vliegen, E M ^b   Baeten, C G ^c   Nagengast, F M ^d   Van Der Bijl, J ^e   Van Dalsen, A D ^f   Kleibeuker, J H ^g   Dekker, E ^b   Langers, A M ^h   Vecht, J ^f   Peters, F T ^g   Van Dam, R ^c   Van Gemert, W G ^c   Stuifbergen, W N ⁱ   Schouten, W R ^j   Gelderblom, H ^h   Vasen, H F A ^a,h  

^a Foundation for the Detection of Hereditary Tumours   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Sittard Geleen Heerlen   (Netherlands)

^f ISALA HOSPITAL   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CPRLab   (Netherlands)

^j ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

desmoid tumour; desmoid type fibromatosis; familial adenomatous polyposis; management

Indexed keywords

ANASTROZOLE; ANTIESTROGEN; ANTINEOPLASTIC AGENT; CARBOPLATIN; CELECOXIB; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FULVESTRANT; GONADORELIN AGONIST; IFOSFAMIDE; IMATINIB; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TAMOXIFEN; TOREMIFENE; VINBLASTINE;

ABDOMINAL FIBROMATOSIS; ABDOMINAL WALL; ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; DESMOID TUMOR; FAMILIAL POLYPOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURGERY; THERAPY; TUMOR GROWTH; TUMOR NECROSIS; TUMOR REGRESSION;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; COLECTOMY; COMBINED MODALITY THERAPY; FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650892973     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605997     Document Type: Article

References (29)

1. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33: 639-642 (Pubitemid 20251985)
2. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Onc 17: 158-167
3. Bertagnolli MM, Morgan JA, Fletcher CDM, Raut CP, Dileo P, Gill RR, Demetri GD, George S (2008) Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer 44: 2404-2410
4. Bertario L, Russo A, Sala P, Eboli M, Giarola M, Varesco L, Pierotti MA, Radice P, Hereditary Colorectal Tumours Registry (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95: 102-107
5. Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A, Le Pechoux C (2008) Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. EJSO 34: 462-468
6. Casali PG, Blay JY, ESMO/CONTICANET/EUROBONET Consensus Panel of experts (2010) Soft tissue sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5): v198-v203
7. Clark SK, Neale KF, Landgrebe JC, Phillips RK (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86: 1185-1189
8. Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I (2009) Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer 45: 2930-2934
9. De Camargo VP, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, Ahn LS, Maki RG (2010) Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 116: 2258-2265
10. Fallen T, Wilson M, Morlan B, Lindor NM (2006) Desmoid tumors-a characterization of patients seen at Mayo Clinic 1976-1999. Fam Cancer 5: 191-194
11. Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Pechoux C, Casali PG, Le Cesne A, Gronchi A, Bonvalot S (2009) Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 16: 2587-2593
12. Gega M, Yanagi H, Yoshikawa R, Noda M, Ikeuchi H, Tsukamoto K, Oshima T, Fujiwara Y, Gondo N, Tamura K, Utsunomiya J, Hashimoto-Tamaoki T, Yamamura T (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24: 102-105
13. Goldblum J, Fletcher JA (2002) Desmoid-type fibromatoses. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK, Mertens F (eds) pp 83-84. IARC Press: Lyon
14. Guadagnolo BA, Zagars GK, Ballo MT (2008) Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys 71: 441-447
15. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G (2004) High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100: 612-620
16. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA (2006) Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24: 1195-1203
17. Heiskanen I, Järvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorect Dis 11: 157-162
18. Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14: 181-190
19. Latchford AR, Sturt NJH, Neale K, Rogers PA, Phillips RKS (2006) A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93: 1258-1264
20. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25: 1785-1791
21. Lynch HT, Lynch JF, Lynch PM, Attard T (2008) Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 7: 27-39
22. Melis M, Zager JS, Sondak VK (2008) Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98: 594-602
23. Nieuwenhuis MH, Casparie M, Mathus-Vliegen E, Dekkers OM, Vasen HFA (2010) A nation-wide study comparing sporadic and familial adenomatous polyposis (FAP) related desmoid-type fibromatoses. Int J Cancer, Doi: 10.1002/ijc.25664
24. Nuyttens JJ, Rust PF, Thomas CR, Turrisi III AT (2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles. Cancer 88: 1517-1523
25. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ (1994) Desmoid tumors in patients with familial adenomatous polyposis. Cancer 74: 1270-1274
26. Sleijfer S (2009) Management of aggressive fibromatosis: can we unravel the maze of treatment options? Eur J Cancer 45: 2928-2929
27. Stoeckle E, Coindre JM, Longy M, Bui Nguyen Binh M, Kantor G, Kind M, Tunon de Lara C, Avril A, Bonichon F, Nguyen Bui B (2009) A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 35: 129-134
28. Tolan S, Shanks JH, Loh MY, Taylor B, Wylie JP (2007) Fibromatosis: benign by name but not necessarily by nature. Clin Oncol 19: 319-326
29. Wcisio G, Szarlej-Wcisio K, Szczylic C (2007) Control of aggressive fibromatosis by treatment with imatinib mesylate. A case-report and review of the literature. J Cancer Res Clin Oncol 133: 533-538